ECSP993181A - Procedimiento para la preparacion de una composicion de alta pureza de (7alfa, 17alfa)- 17 - hidroxi-7-19-nor-17- pregn-5(10) -en -20-in-3-ona - Google Patents

Procedimiento para la preparacion de una composicion de alta pureza de (7alfa, 17alfa)- 17 - hidroxi-7-19-nor-17- pregn-5(10) -en -20-in-3-ona

Info

Publication number
ECSP993181A
ECSP993181A ECSP993181A ECSP993181A EC SP993181 A ECSP993181 A EC SP993181A EC SP993181 A ECSP993181 A EC SP993181A EC SP993181 A ECSP993181 A EC SP993181A
Authority
EC
Ecuador
Prior art keywords
preparation
high purity
7alfa
17alfa
hidroxi
Prior art date
Application number
Other languages
English (en)
Inventor
Peter Huub Gerard Maria Kirchholtes
Gerard Arnoud Jozef Maria Tereza Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP993181 priority Critical patent/ECSP993181A/es
Publication of ECSP993181A publication Critical patent/ECSP993181A/es

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invención se refiere a un procedimiento para la preparación de una composición de alta pureza de (7,17)-17-hidroxi.7-metil-19-nor-17-oregn-4-en-20-in-3-ona. Esta composición puede ser usada como una fuente para la preparación de unidades de dosificación farmacéuticas estables.
ECSP993181 1999-10-15 1999-10-15 Procedimiento para la preparacion de una composicion de alta pureza de (7alfa, 17alfa)- 17 - hidroxi-7-19-nor-17- pregn-5(10) -en -20-in-3-ona ECSP993181A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP993181 ECSP993181A (es) 1999-10-15 1999-10-15 Procedimiento para la preparacion de una composicion de alta pureza de (7alfa, 17alfa)- 17 - hidroxi-7-19-nor-17- pregn-5(10) -en -20-in-3-ona

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP993181 ECSP993181A (es) 1999-10-15 1999-10-15 Procedimiento para la preparacion de una composicion de alta pureza de (7alfa, 17alfa)- 17 - hidroxi-7-19-nor-17- pregn-5(10) -en -20-in-3-ona

Publications (1)

Publication Number Publication Date
ECSP993181A true ECSP993181A (es) 1999-12-23

Family

ID=42044170

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP993181 ECSP993181A (es) 1999-10-15 1999-10-15 Procedimiento para la preparacion de una composicion de alta pureza de (7alfa, 17alfa)- 17 - hidroxi-7-19-nor-17- pregn-5(10) -en -20-in-3-ona

Country Status (1)

Country Link
EC (1) ECSP993181A (es)

Similar Documents

Publication Publication Date Title
SE9904505D0 (sv) Novel compounds
CL2009001682A1 (es) Composición farmacéutica espontáneamente dispersable para administración oral que comprende n-benzoil-estaurosporina; método para incrementar los niveles de biodisponibilidad. (divisional de la solocitud 333-00).
BR0007781A (pt) Conjugado fisiologicamente ativo, composição, e, processo para a produção de um conjugado de peg-gcsf
NO20011721D0 (no) N-aralkylaminotetraliner som ligander for neuropeptid Y Y5 reseptor
NZ516347A (en) Indanyl-substituted benzenecarboxamides, process for their preparation, their use as a medicament and pharmaceutical formulations containing them
SE0001899D0 (sv) New compounds
EE200300033A (et) Tsüklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon
EE02962B1 (et) Mometasoonfuroaadi monohüdraat, selle valmistamismeetod ja farmatseutilised kompositsioonid
NZ527867A (en) Oral pharmaceutical composition of cefpodoxime proxetil
IL160171A0 (en) Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
AU2002214389A1 (en) Pharmaceutical composition containing honey for the treatment of wounds
SE0102055D0 (sv) New Compounds
SE0102440D0 (sv) New compound
CA2344686A1 (en) High purity composition comprising (7.alpha.,17.alpha.)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one
EP1019047A4 (en) ANTITHROMBOTIC AGENTS
BR0114395A (pt) Composição farmacêutica para administração por suprimento via oral
IL163608A (en) Sulfonanilides are conserved in their amino / amino acids and derivatives, their process, their pharmaceutical preparations, and their conjugated antibodies and their use in the preparation of drugs for the treatment of culture disorders
NZ515108A (en) Novel ribose-substituted aromatic amides, method for the production and use thereof as medicaments
ES2192789T3 (es) Derivados de hidrazono-benzazuleno, composiciones farmaceuticas y compuestos intermedios.
EP1027051A4 (en) ANTITHROMBOTIC AGENTS
SE0000303D0 (sv) Novel compounds
ECSP993181A (es) Procedimiento para la preparacion de una composicion de alta pureza de (7alfa, 17alfa)- 17 - hidroxi-7-19-nor-17- pregn-5(10) -en -20-in-3-ona
YU87501A (sh) Farmaceutski kompleksi
YU48200A (sh) Farmaceutski preparati
SE9902742D0 (sv) New pharmaceutical formultion